EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.67 | LY294002 | treatment inhibits SARS-CoV S-mediated entry into VeroE6 cells | Chlorocebus sabaeus | |
2.7.1.67 | Wortmannin | treatment inhibits SARS-CoV S-mediated entry into VeroE6 cells | Chlorocebus sabaeus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.67 | Chlorocebus sabaeus | - |
- |
- |
2.7.1.67 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.1.67 | HEK-293 cell | - |
Homo sapiens | - |
2.7.1.67 | Vero-E6 cell | - |
Chlorocebus sabaeus | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.1.67 | phosphatidylinositol 4-kinase IIIbeta | - |
Homo sapiens |
2.7.1.67 | phosphatidylinositol 4-kinase IIIbeta | - |
Chlorocebus sabaeus |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.1.67 | malfunction | knockdown of isozyme phosphatidylinositol 4-kinase IIIbeta inhibits SARS-CoV S-mediated entry into VeroE6 cells | Chlorocebus sabaeus |
2.7.1.67 | physiological function | isozyme phosphatidylinositol 4-kinase IIIbeta is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry, overview | Chlorocebus sabaeus |
2.7.1.67 | physiological function | isozyme phosphatidylinositol 4-kinase IIIbeta is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry. PI4P plays an essential role in SARS-CoV spike-mediated entry, which is regulated by the PI4P lipid microenvironment, overview | Homo sapiens |